Ameritas Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Sell |
7,595
-2,978
| -28% | -$247K | 0.03% | 446 |
|
|
2025
Q1 | $903K | Sell |
10,573
-111
| -1% | -$9.48K | 0.04% | 424 |
|
|
2024
Q4 | $962K | Buy |
10,684
+1,137
| +12% | +$102K | 0.03% | 426 |
|
|
2024
Q3 | $943K | Sell |
9,547
-274
| -3% | -$27.1K | 0.04% | 398 |
|
|
2024
Q2 | $911K | Sell |
9,821
-615
| -6% | -$57K | 0.03% | 435 |
|
|
2024
Q1 | $948K | Sell |
10,436
-617
| -6% | -$56.1K | 0.04% | 392 |
|
|
2023
Q4 | $1.01M | Sell |
11,053
-253
| -2% | -$23.2K | 0.06% | 282 |
|
|
2023
Q3 | $793K | Sell |
11,306
-2,622
| -19% | -$184K | 0.04% | 391 |
|
|
2023
Q2 | $1.14M | Sell |
13,928
-8,133
| -37% | -$665K | 0.15% | 161 |
|
|
2023
Q1 | $1.72M | Sell |
22,061
-6,780
| -24% | -$529K | 0.09% | 219 |
|
|
2022
Q4 | $2.39M | Buy |
28,841
+9,968
| +53% | +$827K | 0.11% | 188 |
|
|
2022
Q3 | $1.5M | Buy |
18,873
+62
| +0.3% | +$4.92K | 0.09% | 221 |
|
|
2022
Q2 | $1.4M | Buy |
18,811
+9,859
| +110% | +$732K | 0.08% | 237 |
|
|
2022
Q1 | $805K | Buy |
8,952
+462
| +5% | +$41.5K | 0.03% | 379 |
|
|
2021
Q4 | $951K | Buy |
+8,490
| New | +$951K | 0.03% | 344 |
|